Advertisement

Related Videos

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Peter Clark, MA, MD, FRCP: A Payer Perspective

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Advertisement

Advertisement




Aug
27
Today In Oncology
Cleveland Clinic President Discusses AI Summit for Health-Care Professionals
Dr. Gary R. Morrow, a Pioneer in Cancer Research, Dies at 82
FDA Approves Zanidatamab Combination Regimens for HER2 Gastric GEJ or Esophageal Cancer
ASCO Remembers Supportive Care and Symptom Management Pioneer Gary R. Morrow, PhD, MS
FDA Approves Daraxonrasib for Metastatic Pancreatic Adenocarcinoma
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo